Evidence map›Paper›PMID 24933248›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2014

FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathway.

Lance A Stechschulte, Terry D Hinds, Simona S Ghanem, Weinian Shou, Sonia M Najjar, Edwin R Sanchez

Open access · greenAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 70 citations in OpenAlex.

  1. GαMetabolites · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Knocking out Fkbp51 decreases CClCell & bioscience · 2024
    Article
  7. Review
  8. Article
  9. FKBP51 and the molecular chaperoning of metabolism.Trends in endocrinology and metabolism: TEM · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Chaperoning skin atrophy.Oncotarget · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lance A StechschulteCenter for Diabetes and Endocrine Research (L.A.S., T.D.H., S.S.G., S.M.N., E.R.S.), Department of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, Ohio 43614; and Herman B. Wells Center for Pediatric Research (W.S.), Section of Pediatric Cardiology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana 46202.
Terry D Hinds
Simona S Ghanem
Weinian Shou
Sonia M Najjar
Edwin R Sanchez
University of Toledo · USIndiana University – Purdue University Indianapolis · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Martin G Myers · 2013 to 2026
$24.3M
SUBSTRATES AND INSULIN RECEPTOR ENDOCYTOSISR01DK054254 · NIDDK · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI NAJJAR, SONIA M. · 2000 to 2021
$5.8M
PRIDE: Functional and Translational Genomics of Blood DisordersR25HL106365 · NHLBI · AUGUSTA UNIVERSITY · PI PACE, BETTY SUE · 2010 to 2024
$5.2M
TPR Proteins in Steroid Receptor Signaling &PhysiologyR01DK070127 · NIDDK · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SANCHEZ, EDWIN RAMON · 2005 to 2009
$1.3M
Role of FKBP52 in androgen signaling and hypospadiasR01DK073402 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SHOU, WEINIAN · 2006 to 2009
$1.1M
Antioxidant-PPARalpha interaction and hypertensionK01HL125445 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI HINDS, TERRY D · 2015 to 2019
$779k
Insulin resistance in the pathogenesis of NASHR01DK083850 · NIDDK · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI NAJJAR, SONIA M. · 2009 to 2010
$749k
NHLBI NIH HHS HL106365NHLBI NIH HHS K01 HL125445NHLBI NIH HHS R25 HL106365NIDDK NIH HHS DK054254NIDDK NIH HHS DK083850NIDDK NIH HHS DK70127NIDDK NIH HHS DK73402NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK054254NIDDK NIH HHS R01 DK070127NIDDK NIH HHS R01 DK073402NIDDK NIH HHS R01 DK083850
6 · The paper itself

Abstract

FK506-binding protein 51 (FKBP51) is a negative regulator of glucocorticoid receptor-α (GRα), although the mechanism is unknown. We show here that FKBP51 is also a chaperone to peroxisome proliferator-activated receptor-γ (PPARγ), which is essential for activity, and uncover the mechanism underlying this differential regulation. In COS-7 cells, FKBP51 overexpression reduced GRα activity at a glucocorticoid response element-luciferase reporter, while increasing PPARγ activity at a peroxisome proliferator response element reporter. Conversely, FKBP51-deficient (knockout) (51KO) mouse embryonic fibroblasts (MEFs) showed elevated GRα but reduced PPARγ activities compared with those in wild-type MEFs. Phosphorylation is known to exert a similar pattern of reciprocal modulation of GRα and PPARγ. Knockdown of FKBP51 in 3T3-L1 preadipocytes increased phosphorylation of PPARγ at serine 112, a phospho-residue that inhibits activity. In 51KO cells, elevated phosphorylation of GRα at serines 220 and 234, phospho-residues that promote activity, was observed. Because FKBP51 is an essential chaperone to the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase, Akt signaling was investigated. Elevated Akt activation and increased activation of p38 kinase, a downstream target of Akt that phosphorylates GRα and PPARγ, were seen in 51KO MEFs, causing activation and inhibition, respectively. Inactivation of p38 with PD169316 reversed the effects of FKBP51 deficiency on GRα and PPARγ activities and reduced PPARγ phosphorylation. Last, loss of FKBP51 caused a shift of PPARγ from cytoplasm to nucleus, as previously shown for GRα. A model is proposed in which FKBP51 loss reciprocally regulates GRα and PPARγ via 2 complementary mechanisms: activation of Akt-p38-mediated phosphorylation and redistribution of the receptors to the nucleus for direct targeting by p38.

Indexed as

3T3-L1 CellsAnimalsCell NucleusChlorocebus aethiopsCOS CellsInsulinMAP Kinase Signaling SystemMicePhosphorylationPPAR gammaProtein Processing, Post-TranslationalProto-Oncogene Proteins c-aktReceptors, GlucocorticoidTacrolimus Binding Protein 5Tacrolimus Binding Proteinsglucocorticoid receptor alphaInsulinPPAR gammaProto-Oncogene Proteins c-aktReceptors, GlucocorticoidTacrolimus Binding Protein 5Tacrolimus Binding Proteins

Identifiers

PMID24933248
PMCPMC4116593
OpenAlexW2136912411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.